TL;DR
- Trans healthcare is governed by guidelines, not enforceable regulation — meaning the same treatment can look completely different depending on where you live, who you see, and whether your clinician has any trans-specific training
- Gatekeeping — requiring psychiatric diagnosis or mental health sign-off before accessing HRT — remains the dominant model in many countries, despite no evidence it improves outcomes
- Real-world audits show a majority of trans patients do not receive monitoring that meets guideline standards
- The problem is structural, not just individual — inconsistency is built into how trans healthcare is organised globally
- Knowing what good care looks like is not a luxury. In a system where standards are applied inconsistently, it may be one of the most important protections you have
Trans healthcare exists. In most places, that is about the best you can say about it.
There are international guidelines. WPATH publishes Standards of Care — now on version 8. The Endocrine Society publishes clinical practice guidelines. These documents represent the closest thing the field has to a global standard.
They are not regulation. They are not enforceable. A clinician who ignores them faces no professional sanction specific to trans healthcare. A healthcare system that doesn’t implement them faces no accountability mechanism. They are recommendations, and whether any individual trans person receives care that reflects them is largely a matter of luck — geography, system, clinician, waiting time, and whether anyone in the room has any trans-specific expertise.
What the evidence shows
A UK primary care audit found that up to two-thirds of trans patients did not receive all recommended monitoring standards when assessed against Endocrine Society guidelines. The most striking finding was not clinician incompetence — it was systemic inconsistency. Different gender identity clinics in the same country recommended different monitoring schedules. There was no agreed primary care audit standard to measure against. The audit highlighted the absence of agreed standards and quality metrics that are routine features of many other areas of medicine.
A global expert survey across 39 countries found that transgender healthcare delivery varies enormously — between centralised specialist models, decentralised primary care models, and everything in between. The survey itself did not establish whether one model produces better outcomes than the other; its authors explicitly flagged this as an open question for future research. Subsequent, more targeted research from the same group has started to answer it, and the early findings cut against the idea that the model doesn’t matter — one study found that patients in decentralised care settings reported lower psychosocial health scores than those in centralised care, with a moderate-to-large effect — although this was a retrospective, single-centre study, causality cannot be inferred, and further research is needed. In large parts of the world, specialist trans healthcare does not exist at all.
The gatekeeping problem
In many countries, accessing HRT requires navigating a gatekeeping model: psychiatric assessment, formal diagnosis of gender dysphoria (or its ICD-11 equivalent, gender incongruence), often a waiting period, and formal sign-off from a mental health professional before a prescriber will act. A 2024 mapping exercise found that only a handful of EU member states — including Malta, Denmark, and some regions of Spain — do not require a psychiatric diagnosis as a condition of access to trans-specific healthcare.
The evidence behind gatekeeping is weak. There is no evidence that requiring psychiatric sign-off prevents regret or improves outcomes. There is evidence that prolonged delays associated with these systems are linked to adverse mental health outcomes, and that extensive assessment requirements may create additional barriers for people with complex mental health histories.
Why this matters for your care
If you are receiving trans healthcare — or trying to access it — the gap between what guidelines recommend and what you are actually receiving may be substantial. Most trans people never know what they are not getting. They may not know that the Endocrine Society recommends quarterly monitoring during the first year. They may not know their testosterone result should be interpreted against a female reference range. They may not know there is a difference between a clinician who has read the literature and one who is prescribing HRT for the first time.
The knowledge gap is not incidental to the problem. It is the problem. In a system where standards are applied inconsistently, informed patients are often better equipped to advocate for their own care, and knowing what good care looks like is not a luxury — it may be one of the most important protections patients have.
⚠️ Note: The monitoring audit cited is from a UK primary care setting and should not be generalised as a precise global figure. The structural inconsistencies described are, however, documented across multiple healthcare systems and countries.
Sources
- Kyriakou A, et al. Care of Transgender Patients: A General Practice Quality Improvement Approach. Healthcare. 2022;10(1):121.
- Koehler A, Strauss B, Briken P, Szuecs D, Nieder TO. Centralized and Decentralized Delivery of Transgender Health Care Services: A Systematic Review and a Global Expert Survey in 39 Countries. Front Endocrinol. 2021;12:717914.
- Koehler A, Strauss B, Briken P, Fisch M, Soave A, Riechardt S, Nieder TO. Exploring the Relationship between (De-)Centralized Health Care Delivery, Client-Centeredness, and Health Outcomes — Results of a Retrospective, Single-Center Study of Transgender People Undergoing Vaginoplasty. Int J Impot Res. 2023.
- TGEU (Trans Europe and Central Asia). Trans Health Map 2024. Published October 2024.
- Hembree WC, Cohen-Kettenis PT, Gooren L, et al. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2017;102(11):3869–3903.
